Painchek (ASX:PCK)
ASX announcement history & article coverage
Transparent by design.
Announcments by Painchek (ASX:PCK) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Notification regarding unquoted securities - PCK
PainChek expands Sabra contracts to 23 US communities
PainChek expands Sabra contracts to 23 US communities with 808 licences
Change of Director's Interest Notice x3
Application for quotation of securities - PCK
Notice of Annual General Meeting/Proxy Form
Corporate Governance Statement and Appendix 4G 2026
Annual Report to shareholders
PainChek grows recurring revenue and US market access but flags going concern uncertainty
Final Director's Interest Notice
Investor Webinar Invite
Resignation of Non-Executive Director
Appendix 4E and Financial Report
PainChek Investor Webinar
Update - Notification regarding unquoted securities - PCK
Change of Director's Interest Notice x 4
Quarterly Activities/Appendix 4C Cash Flow Report
PainChek reports 5.9% ARR growth, first US commercial deployments, and improved cash flow
PainChek receives $1.123 million R&D tax incentive refund
PainChek receives $1.123 million R&D tax incentive refund to support product development and US market entry
